SMT201700106B - Produzione di n-acetilgalattosammin-6-solfatasi di essere umano altamente fosforilata attiva e suoi usi - Google Patents

Produzione di n-acetilgalattosammin-6-solfatasi di essere umano altamente fosforilata attiva e suoi usi

Info

Publication number: SMT201700106B
Authority: SM; San Marino
Prior art keywords: sulphatasis; acetylgalactosammin; phosphorilated; activity; production
Prior art date: 2010-07-22

Application number

SM201700106T

Other languages

English (en)

Inventor

Vish Koppaka

Michel Claude Vellard

Kidisti Araya

Augustus O Okhamafe

Original Assignee

Biomarin Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-07-22

Filing date

2017-02-16

Publication date

2017-03-08

2017-02-16 Application filed by Biomarin Pharm Inc filed Critical Biomarin Pharm Inc

2017-03-08 Publication of SMT201700106B publication Critical patent/SMT201700106B/it

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/06—Sulfuric ester hydrolases (3.1.6)
- C12Y301/06004—N-Acetylgalactosamine-6-sulfatase (3.1.6.4)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Gastroenterology & Hepatology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Hematology (AREA)
Obesity (AREA)
Enzymes And Modification Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

SM201700106T 2010-07-22 2017-02-16 Produzione di n-acetilgalattosammin-6-solfatasi di essere umano altamente fosforilata attiva e suoi usi SMT201700106B (it)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US36671410P	2010-07-22	2010-07-22

Publications (1)

Publication Number	Publication Date
SMT201700106B true SMT201700106B (it)	2017-03-08

Family

ID=44543776

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SM20170106T SMT201700106T1 (it)	2010-07-22	2011-07-22	Produzione di n-acetilgalattosammin-6-solfatasi di essere umano altamente fosforilata attiva e suoi usi
SM201700106T SMT201700106B (it)	2010-07-22	2017-02-16	Produzione di n-acetilgalattosammin-6-solfatasi di essere umano altamente fosforilata attiva e suoi usi

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
SM20170106T SMT201700106T1 (it)	2010-07-22	2011-07-22	Produzione di n-acetilgalattosammin-6-solfatasi di essere umano altamente fosforilata attiva e suoi usi

Country Status (28)

Country	Link
US (3)	US8765437B2 (it)
EP (1)	EP2595650B1 (it)
JP (2)	JP6030553B2 (it)
KR (2)	KR101598897B1 (it)
CN (1)	CN103037895B (it)
AR (2)	AR082319A1 (it)
AU (1)	AU2011280937B2 (it)
BR (1)	BR112013001558B1 (it)
CA (2)	CA3146151A1 (it)
CL (2)	CL2013000219A1 (it)
CY (1)	CY1118934T1 (it)
DK (1)	DK2595650T3 (it)
ES (1)	ES2616263T3 (it)
HR (1)	HRP20170245T1 (it)
HU (1)	HUE033163T2 (it)
IL (2)	IL224125B (it)
LT (1)	LT2595650T (it)
MX (1)	MX341838B (it)
PE (3)	PE20171799A1 (it)
PL (1)	PL2595650T3 (it)
PT (1)	PT2595650T (it)
RS (1)	RS55669B1 (it)
RU (1)	RU2607376C2 (it)
SG (1)	SG187580A1 (it)
SI (1)	SI2595650T1 (it)
SM (2)	SMT201700106T1 (it)
WO (1)	WO2012012718A2 (it)
ZA (1)	ZA201300286B (it)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL3219795T3 (pl) *	2008-01-18	2024-09-16	Biomarin Pharmaceutical Inc.	Wytwarzanie aktywnych wysoce fosforylowanych ludzkich enzymów sulfatazy lizosomalnej i ich zastosowania
US8956859B1 (en)	2010-08-13	2015-02-17	Aviex Technologies Llc	Compositions and methods for determining successful immunization by one or more vaccines
WO2013119715A1 (en) *	2012-02-07	2013-08-15	Saint Louis University	Determination of immunogenic peptides in lysosomal enzymes and induction of oral tolerance
KR101380740B1 (ko)	2012-06-29	2014-04-11	쉐어 휴먼 제네텍 세러피스, 인코포레이티드	이듀로네이트-2-설파타제의 정제
US11529397B2 (en)	2018-01-22	2022-12-20	Saint Louis University	Method of treating mucopolysaccharidosis type IVA
EP3441072B1 (en)	2013-03-13	2020-12-30	Seagen Inc.	Activated carbon filtration for purification of benzodiazepine adcs
JP2016518113A (ja) *	2013-03-13	2016-06-23	シャイアーヒューマンジェネティックセラピーズインコーポレイテッド	リソソーム系酵素の特性評価の方法
BR112015028605A8 (pt) *	2013-05-15	2019-12-24	Univ Minnesota	uso de uma composição e uso de um imunossupressor e uma composição
WO2014201220A1 (en) *	2013-06-12	2014-12-18	The Board Of Trustees Of The University Of Illinois	Methods for detecting prostate cancer
WO2015005961A1 (en)	2013-07-12	2015-01-15	Emd Millipore Corporation	A method of determining virus removal from a sample containing a target protein using activated carbon
WO2016007909A2 (en) *	2014-07-11	2016-01-14	Biostrategies LC	Materials and methods for treating disorders associated with sulfatase enzymes
US10472615B2 (en)	2016-01-21	2019-11-12	Saint Louis University	Reduced immunogenic proteins for lysosomal storage disorders
EP3448885A4 (en)	2016-04-26	2020-01-08	R.P. Scherer Technologies, LLC	ANTIBODY CONJUGATES AND METHOD FOR THE PRODUCTION AND USE THEREOF
KR102286260B1 (ko) *	2017-08-31	2021-08-05	주식회사 녹십자	설파타아제 단백질을 정제하는 방법
SG11202011777PA (en) *	2018-05-30	2020-12-30	Esteve Pharmaceuticals Sa	Adenoassociated virus vectors for the treatment of mucopolysaccharidoses type iv a
RU2763990C2 (ru) *	2020-02-19	2022-01-12	Акционерное общество "ГЕНЕРИУМ"	Клетка, продуцирующая с высокой эффективностью активный белок арилсульфатазу в, и способ получения этой клетки
US20230193205A1 (en) *	2020-04-19	2023-06-22	Figene, Llc	Gene modified fibroblasts for therapeutic applications
US20250134967A1 (en) *	2022-02-07	2025-05-01	M6P Therapeutics, Inc.	Compositions comprising acid alpha glucosidase and methods of use thereof
TW202403043A (zh) *	2022-03-18	2024-01-16	美商健臻公司	重組人類酸性鞘磷脂酶醫藥組合物及方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4179337A (en)	1973-07-20	1979-12-18	Davis Frank F	Non-immunogenic polypeptides
US4394448A (en)	1978-02-24	1983-07-19	Szoka Jr Francis C	Method of inserting DNA into living cells
US4391904A (en)	1979-12-26	1983-07-05	Syva Company	Test strip kits in immunoassays and compositions therein
US4554101A (en)	1981-01-09	1985-11-19	New York Blood Center, Inc.	Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US5186941A (en)	1983-05-06	1993-02-16	Vestar, Inc.	Vesicle formulation for the controlled release of therapeutic agents
JPS62122588A (ja)	1985-11-22	1987-06-03	Taiyo Fishery Co Ltd	純コンドロイチナ−ゼの製造法
US6048729A (en)	1987-05-01	2000-04-11	Transkaryotic Therapies, Inc.	In vivo protein production and delivery system for gene therapy
PT101031B (pt)	1991-11-05	2002-07-31	Transkaryotic Therapies Inc	Processo para o fornecimento de proteinas por terapia genetica
US5824784A (en)	1994-10-12	1998-10-20	Amgen Inc.	N-terminally chemically modified protein compositions and methods
TW492882B (en)	1997-11-28	2002-07-01	Caleb Pharmaceuticals Inc	Cholinergic antagonist plaster composition
US6689600B1 (en) *	1998-11-16	2004-02-10	Introgen Therapeutics, Inc.	Formulation of adenovirus for gene therapy
US7083793B2 (en)	1999-02-26	2006-08-01	Millennium Pharmaceuticals, Inc.	Tango 243 polypeptides and uses thereof
US6534300B1 (en)	1999-09-14	2003-03-18	Genzyme Glycobiology Research Institute, Inc.	Methods for producing highly phosphorylated lysosomal hydrolases
US6261595B1 (en)	2000-02-29	2001-07-17	Zars, Inc.	Transdermal drug patch with attached pocket for controlled heating device
RU2195492C2 (ru) *	2000-09-04	2002-12-27	Институт физиологии Коми научного центра Уральского отделения РАН	Способ получения пектолитического ферментного препарата
CA2435972C (en)	2001-01-26	2011-09-13	University Of Lausanne	Matrix attachment regions and methods for use thereof
JP2006508643A (ja) *	2002-07-01	2006-03-16	アーキオンライフサイエンシーズエルエルシーディー／ビー／エーバイオ−テクニカルリソーセズディビジョン	グルコサミンおよびｎ−アセチルグルコサミン製造のためのプロセスおよび材料
EP2325302B1 (en)	2003-02-11	2016-01-06	Shire Human Genetic Therapies, Inc.	Cells that coexpress a sulfatase and a C-formylglycine generating enzyme and methods and uses thereof
JP2007277094A (ja) *	2004-06-29	2007-10-25	Chemo Sero Therapeut Res Inst	改変ダニ主要アレルゲン含有医薬組成物
WO2006073846A2 (en) *	2004-12-22	2006-07-13	Ambrx, Inc.	Methods for expression and purification of recombinant human growth hormone
JP2009534390A (ja) *	2006-04-21	2009-09-24	アムジェンインコーポレイテッド	生物医薬品製剤のための緩衝剤
US20080231439A1 (en)	2007-03-22	2008-09-25	Inventec Corporation	Activity Detection Circuit for a Storage Device
KR20210049186A (ko) *	2007-11-30	2021-05-04	애브비 바이오테크놀로지 리미티드	단백질 제형 및 이의 제조방법
PL3219795T3 (pl) *	2008-01-18	2024-09-16	Biomarin Pharmaceutical Inc.	Wytwarzanie aktywnych wysoce fosforylowanych ludzkich enzymów sulfatazy lizosomalnej i ich zastosowania
US7722865B2 (en) *	2008-01-18	2010-05-25	Biomarin Pharmaceutical Inc.	Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
EP2196476A1 (en) *	2008-12-10	2010-06-16	Novartis Ag	Antibody formulation

2011
- 2011-07-21 AR ARP110102649A patent/AR082319A1/es not_active Application Discontinuation
- 2011-07-22 KR KR1020137004487A patent/KR101598897B1/ko active Active
- 2011-07-22 PT PT117516898T patent/PT2595650T/pt unknown
- 2011-07-22 SM SM20170106T patent/SMT201700106T1/it unknown
- 2011-07-22 PE PE2017001626A patent/PE20171799A1/es unknown
- 2011-07-22 MX MX2013000908A patent/MX341838B/es active IP Right Grant
- 2011-07-22 ES ES11751689.8T patent/ES2616263T3/es active Active
- 2011-07-22 DK DK11751689.8T patent/DK2595650T3/en active
- 2011-07-22 CA CA3146151A patent/CA3146151A1/en active Pending
- 2011-07-22 US US13/188,907 patent/US8765437B2/en active Active
- 2011-07-22 HR HRP20170245TT patent/HRP20170245T1/hr unknown
- 2011-07-22 SI SI201131104A patent/SI2595650T1/sl unknown
- 2011-07-22 RS RS20170165A patent/RS55669B1/sr unknown
- 2011-07-22 LT LTEP11751689.8T patent/LT2595650T/lt unknown
- 2011-07-22 PE PE2013000110A patent/PE20131140A1/es not_active Application Discontinuation
- 2011-07-22 BR BR112013001558-6A patent/BR112013001558B1/pt active IP Right Grant
- 2011-07-22 JP JP2013520881A patent/JP6030553B2/ja active Active
- 2011-07-22 KR KR1020157007141A patent/KR101949906B1/ko active Active
- 2011-07-22 CN CN201180035900.4A patent/CN103037895B/zh active Active
- 2011-07-22 HU HUE11751689A patent/HUE033163T2/en unknown
- 2011-07-22 WO PCT/US2011/045011 patent/WO2012012718A2/en not_active Ceased
- 2011-07-22 EP EP11751689.8A patent/EP2595650B1/en active Active
- 2011-07-22 PL PL11751689T patent/PL2595650T3/pl unknown
- 2011-07-22 PE PE2017001625A patent/PE20171798A1/es unknown
- 2011-07-22 RU RU2013107765A patent/RU2607376C2/ru active
- 2011-07-22 CA CA2805673A patent/CA2805673C/en active Active
- 2011-07-22 AU AU2011280937A patent/AU2011280937B2/en active Active
- 2011-07-22 SG SG2013004841A patent/SG187580A1/en unknown
2013
- 2013-01-07 IL IL224125A patent/IL224125B/en active IP Right Grant
- 2013-01-11 ZA ZA2013/00286A patent/ZA201300286B/en unknown
- 2013-01-22 CL CL2013000219A patent/CL2013000219A1/es unknown
2014
- 2014-05-19 US US14/281,538 patent/US8940513B2/en active Active
- 2014-12-17 US US14/573,907 patent/US9567572B2/en active Active
2016
- 2016-07-15 JP JP2016140213A patent/JP2016178950A/ja not_active Withdrawn
2017
- 2017-02-15 CY CY20171100207T patent/CY1118934T1/el unknown
- 2017-02-16 SM SM201700106T patent/SMT201700106B/it unknown
- 2017-03-02 CL CL2017000498A patent/CL2017000498A1/es unknown
2018
- 2018-06-26 IL IL260282A patent/IL260282B/en active IP Right Grant
2020
- 2020-07-31 AR ARP200102165A patent/AR119552A2/es unknown

Also Published As

Publication number	Publication date
US8940513B2 (en)	2015-01-27
RU2013107765A (ru)	2014-08-27
JP6030553B2 (ja)	2016-11-24
BR112013001558B1 (pt)	2022-08-16
HRP20170245T1 (hr)	2017-04-21
CN103037895A (zh)	2013-04-10
MX2013000908A (es)	2013-07-05
EP2595650B1 (en)	2016-11-16
PE20131140A1 (es)	2013-10-17
ZA201300286B (en)	2014-03-26
US20160186149A1 (en)	2016-06-30
KR20150038715A (ko)	2015-04-08
AU2011280937A1 (en)	2013-01-31
US20140341878A1 (en)	2014-11-20
US9567572B2 (en)	2017-02-14
BR112013001558A2 (pt)	2020-08-04
ES2616263T3 (es)	2017-06-12
RU2607376C2 (ru)	2017-01-10
AR119552A2 (es)	2021-12-29
PE20171798A1 (es)	2017-12-28
LT2595650T (lt)	2017-03-10
CY1118934T1 (el)	2018-01-10
RS55669B1 (sr)	2017-06-30
SMT201700106T1 (it)	2017-03-08
SG187580A1 (en)	2013-03-28
CA2805673C (en)	2022-04-05
KR20130105605A (ko)	2013-09-25
SI2595650T1 (sl)	2017-04-26
IL260282B (en)	2020-05-31
JP2013532986A (ja)	2013-08-22
AR082319A1 (es)	2012-11-28
WO2012012718A2 (en)	2012-01-26
PE20171799A1 (es)	2017-12-28
CL2013000219A1 (es)	2014-07-11
US20120189605A1 (en)	2012-07-26
DK2595650T3 (en)	2017-02-27
PL2595650T3 (pl)	2017-06-30
CL2017000498A1 (es)	2017-11-24
CA3146151A1 (en)	2012-01-26
US8765437B2 (en)	2014-07-01
KR101949906B1 (ko)	2019-04-22
CN103037895B (zh)	2016-11-09
EP2595650A2 (en)	2013-05-29
HUE033163T2 (en)	2017-11-28
KR101598897B1 (ko)	2016-03-03
PT2595650T (pt)	2017-02-22
MX341838B (es)	2016-09-05
AU2011280937B2 (en)	2016-06-09
IL260282A (en)	2018-07-31
WO2012012718A3 (en)	2012-04-05
CA2805673A1 (en)	2012-01-26
IL224125B (en)	2019-02-28
JP2016178950A (ja)	2016-10-13

Publication	Publication Date	Title
SMT201700106B (it)	2017-03-08	Produzione di n-acetilgalattosammin-6-solfatasi di essere umano altamente fosforilata attiva e suoi usi
SMT201700107B (it)	2017-03-08	Produzione di n-acetilgalattosammin-6-solfatasi di essere umano altamente fosforilata attiva e suoi usi
IL267547A (en)	2019-08-29	Sensing or stimulating tissue activity
IL264200B (en)	2022-05-01	Flexible cushioning pads, items incorporating such pads, and methods of making and using
DK2579877T3 (da)	2014-10-13	Morpholinopyrimidiner og deres anvendelse til terapi
PT2503892T (pt)	2017-02-21	Utilização do organismo fungico pythium oligandrum
EP2461765A4 (en)	2016-09-28	COSMETIC SKIN REJUVENATION
IL223725B (en)	2020-03-31	Formulations of rifaximin and uses thereof
IL223341A (en)	2017-02-28	Aqueous alkaline cleaning compositions and methods of their use
EP2774535A4 (en)	2015-07-08	ELECTROCARDIOGRAPH AND BIOELECTRODE PAD
FI20105639A0 (fi)	2010-06-07	Mikroselluloosan valmistus
GB201119023D0 (en)	2011-12-14	Strand displacement activity of modified polymerases and uses thereof
IL225406A0 (en)	2013-06-27	Therapeutic applications of smad7
BR112013011858A2 (pt)	2017-03-21	métodos para reforçar oxigenação de tecido comprometido
BR112013012295A2 (pt)	2016-07-12	"kit cosmético e usos cosméticos do kit"
PT2563806E (pt)	2015-10-09	Leucolectinas humanas e suas utilizações
PL2658374T3 (pl)	2016-05-31	Hepatoochronne działanie garcinolu
PT2632885T (pt)	2018-04-04	Compostos carboxilatos de fenilcetona e usos farmacêuticos destes
ME02992B (me)	2018-10-20	Intermedijeri agomelaтina i postupci njihove priprave
GB201003759D0 (en)	2010-04-21	Manufacture of microneedle arrays
ZA201209453B (en)	2015-12-23	Personal care product and manufacture thereof
IT1397473B1 (it)	2013-01-16	Apparecchio portatile di elettrostimolazione del corpo umano
ITMI20112284A1 (it)	2012-06-28	Dispositivo applicatore di prodotto cosmetico e utilizzo di tale dispositivo
FI20095792L (fi)	2011-01-16	Ihmissolujen käyttö
SMT201700386T1 (it)	2017-09-07	Estratto di crusca di seme di coix lacryma-jobi e suo uso